Coura-Vital et al reported a score for predicting mortality from visceral leishmaniasis in Brazil. This can help to identify a patient who may benefit from more aggressive management. The authors are from multiple institutions in Brazil.
Patient selection: visceral leishmaniasis
Parameters:
(1) splenomegaly
(2) edema
(3) weakness
(4) bleeding
(5) jaundice
(6) age in years
(7) HIV co-infection
(8) bacterial infection
Parameters |
Finding |
Points |
splenomegaly |
no |
0 |
|
yes |
1 |
edema |
no |
0 |
|
yes |
1 |
weakness |
no |
0 |
|
yes |
1 |
bleeding |
no |
0 |
|
yes |
3 |
jaundice |
no |
0 |
|
yes |
1 |
HIV |
no |
0 |
|
yes |
1 |
bacterial infection |
no |
0 |
|
yes |
1 |
age |
<= 0.5 years |
5 |
|
0.51 to 1 year |
2 |
|
1.01 to 19 years |
0 |
|
19.01 to 50 years |
2 |
|
50.01 to 64.99 years |
3 |
|
>= 65 years |
5 |
total score =
= SUM(points for all of the parameters)
Interpretation:
• minimum score: 0
• maximum score: 14
Score |
Mortality Rate |
0 |
0.6% |
1 |
0.9 to 1.1% |
2 |
1.5 to 1.9% |
3 |
2.2 to 3.2% |
4 |
3.4 to 5.2% |
5 |
4.8 to 8.3% |
6 |
7.2 to 13% |
7 |
11.2 to 19.5% |
8 |
16.2 to 27.1% |
9 |
23 to 33.8% |
10 |
32.5 to 45.3% |
11 |
44.3 to 56% |
12 |
56.7 to 66.2% |
13 |
69.8 to 76% |
14 |
81.3 to 82.9% |
Performance:
• The area under the ROC curve is 0.80 in the derivation and 0.78 in the validation cohorts.
Specialty: Infectious Diseases